MedTrace Logo

Sleep Investigation in Respirator Treated ICU Patients: the Importance of Intensive Environment

NCT01681043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2015-03-25

No results posted yet for this study

Summary

Sleep investigation in respirator treated ICU patients: the importance of intensive environment.

Sleep disturbances in the ICU seem to lead to development of delirium, prolonged ICU stay and increased mortality.

The hypothesis of this study is: minimizing of disturbing factors in the ICU, such as noise, light, therapeutic and diagnostic procedures between 10 p.m. and 6 a.m. will improve sleep quality in respirator treated ICU patients.

Methods: randomized interventional study. 48-hour polysomnographic sleep measurement acc. AASM's standard in 46 awake respirator treated patients: 24 hours under ordinary circumstances and 24 hours under the protocol 'Quiet in the room' between 10 p.m. and 6 a.m. after randomization.

Conditions

  • Sleep

Interventions

BEHAVIORAL

protocol 'Quiet in the room'

Protocol 'Quite in the room' between 10 p.m. and 6 a.m. * nurse nearby * no visits after 10 p.m. * decreased alarm sound in ventilator and monitor * decreased light intensity * no unnecessary conversations around the patient * medication should be limited to max 1-2 times in this time period * no unnecessary therapeutic or diagnostic procedures in this time period * earplugs and sleep masks

Sponsors & Collaborators

  • Vejle Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01681043 on ClinicalTrials.gov